Two ways were used to block the interaction between FGF2 and FGFR2: one way used shRNA to knockdown FGF2 in MSCs, the other way was FGFR inhibitor BGJ398 to competitively combined with FGFR2 in leukaemia cells. The gene discussed is FGF2; the disease is leukemia.